Voloridge Investment Management
RLAY icon

Voloridge Investment Management’s Relay Therapeutics RLAY Stock Holding History

Voloridge Investment Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-431,150
Closed -$1.13M – 1336
2025
Q1 		$1.13M Sell
431,150
-192,189
-31% -$753K ﹤0.01% 1034
2024
Q4 		$2.57M Sell
623,339
-607,037
-49% -$3.3M 0.01% 912
2024
Q3 		$8.71M Buy
1,230,376
+39,193
+3% +$293K 0.03% 626
2024
Q2 		$7.77M Buy
1,191,183
+984,427
+476% +$6.73M 0.03% 634
2024
Q1 		$1.72M Sell
206,756
-19,556
-9% -$191K 0.01% 883
2023
Q4 		$2.49M Buy
226,312
+82,590
+57% +$697K 0.01% 781
2023
Q3 		$1.21M Buy
+143,722
New +$1.55M 0.01% 1058
2023
Q1 		– Sell
-17,835
Closed -$266K – 1577
2022
Q4 		$266K Sell
17,835
-294,749
-94% -$5.64M ﹤0.01% 1350
2022
Q3 		$6.99M Buy
312,584
+268,406
+608% +$5.89M 0.04% 545
2022
Q2 		$740K Buy
44,178
+37,064
+521% +$794K ﹤0.01% 1254
2022
Q1 		$213K Buy
+7,114
New +$173K ﹤0.01% 1298
2021
Q4 		– Sell
-70,253
Closed -$2.21M – 1809
2021
Q3 		$2.21M Sell
70,253
-79,129
-53% -$2.66M 0.01% 1023
2021
Q2 		$5.47M Sell
149,382
-49,988
-25% -$1.65M 0.04% 608
2021
Q1 		$6.89M Buy
+199,370
New +$8.65M 0.05% 432

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Voloridge Investment Management's RLAY Position: Q2 2025 in Review

Voloridge Investment Management sold out of Relay Therapeutics (RLAY) in Q2 2025, closing a stake of 431,150 shares — an estimated $1.13M sold.

Voloridge Investment Management first reported a position in RLAY in Q1 2021 and held it in 14 quarters. The position peaked at $8.71M in Q3 2024. 208 funds tracked by Wall St. Rank hold RLAY as of Q2 2025.

  • Voloridge Investment Management reported no remaining Relay Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 431,150 Relay Therapeutics shares in Q2 2025, an estimated $1.13M.
  • Voloridge Investment Management first reported a position in Relay Therapeutics in Q1 2021 and held it in 14 quarters.
  • Voloridge Investment Management's Relay Therapeutics position peaked at $8.71M in Q3 2024.
  • 208 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2025.

Based on Voloridge Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.